These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14263010)

  • 41. EFFECT OF 20-METHYLCHOLANTHRENE GIVEN AT BIRTH ON TUMOR DEVELOPMENT IN TWO HIGH-LEUKEMIA STRAINS OF MICE, AKR AND SL.
    NISHIZUKA Y; NAKAKUKI K
    Gan; 1964 Feb; 55():83-5. PubMed ID: 14134002
    [No Abstract]   [Full Text] [Related]  

  • 42. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. STUDIES ON AN ANTITUMOR ANTIBIOTIC, CERVICARCIN. II. ANTITUMOR ACTIVITY OF CERVICARCIN AND ITS DERIVATIES AGAINST SOME OF TRASPLANTABLE MOUSE TUMORS.
    ITAKURA C; SEGA T; SUZUKI S; SUMIKI Y
    J Antibiot (Tokyo); 1963 Nov; 16():231-5. PubMed ID: 14084119
    [No Abstract]   [Full Text] [Related]  

  • 44. CHROMOSOME PATTERNS IN THE AKR MOUSE: SPONTANEOUS LEUKEMIA, ASCITES TRANSFERS, AND TISSUE CULTURE CELL LINES.
    CAILLEAU R; MUNRO MM
    J Natl Cancer Inst; 1964 Nov; 33():813-24. PubMed ID: 14231154
    [No Abstract]   [Full Text] [Related]  

  • 45. PREVENTION OF ANTILEUKEMIC EFFECT OF TEREPHTHALANILIDE DERIVATIVES IN TRANSPLANTED MOUSE LEUKEMIA P815 BY 4,4'-(TEREPHTHALOYLDIIMINO)DIBENZENESULFONIC ACID DISODIUM SALT (NSC-55156).
    BURCHENAL JH; PURPLE JR; SPOONER EB; BERCHTOLD R; HIRT R; FISCHER R; BALSIGER R
    Cancer Chemother Rep; 1964 Dec; 43():5-10. PubMed ID: 14250654
    [No Abstract]   [Full Text] [Related]  

  • 46. Relationship between white blood cell count and diagnosis and therapeutic response in AKR mice with spontaneous leukemia (lymphoma).
    Kende M; Goldberg AI; Glynn JP; Mantel N; Goldin A
    Cancer Chemother Rep; 1972 Dec; 56(6):683-90. PubMed ID: 4660628
    [No Abstract]   [Full Text] [Related]  

  • 47. A CONTRIBUTION TO THE QUESTION OF THE ANTIGENICITY OF SPONTANEOUS LYMPHOID AKR LEUKAEMIA.
    BUBENIK J; ADAMCOVA B; KOLDOVSKY P
    Folia Biol (Praha); 1964; 10():293-300. PubMed ID: 14189806
    [No Abstract]   [Full Text] [Related]  

  • 48. SCREENING DATA FROM THE CANCER CHEMOTHERAPY NATIONAL SERVICE CENTER SCREENING LABORATORIES. XXI.
    LEITER J; ABBOTT BJ; SCHEPARTZ SA
    Cancer Res; 1964 Dec; 24():1093-353. PubMed ID: 14250655
    [No Abstract]   [Full Text] [Related]  

  • 49. EFFECT OF ADMINISTRATION OF THE ENZYME GLUTAMINASE ON THE GROWTH OF CANCER CELLS.
    GREENBERG DM; BLUMENTHAL G; RAMADAN ME
    Cancer Res; 1964 Jul; 24():957-63. PubMed ID: 14195348
    [No Abstract]   [Full Text] [Related]  

  • 50. METABOLISM AND DISTRIBUTION OF 9-BETA-D-ARABINOFURANOSYLADENINE IN MOUSE TISSUES.
    BRINK JJ; LEPAGE GA
    Cancer Res; 1964 Jul; 24():1042-9. PubMed ID: 14195341
    [No Abstract]   [Full Text] [Related]  

  • 51. STUDIES ON THE POSSIBLE ANTI-NEOPLASTIC EFFECT OF THALIDOMIDE.
    BACH A; BICHEL J; HEJGAARD JJ
    Acta Pathol Microbiol Scand; 1963; 59():491-9. PubMed ID: 14080481
    [No Abstract]   [Full Text] [Related]  

  • 52. A follow-up study of the progression or spontaneous regression of leukemia in mouse strains.
    Szöllösi J; Ember I; Trón L; Kertai P
    Cytometry; 1982 Sep; 3(2):110-5. PubMed ID: 6958443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EXPERIMENTAL CHEMOTHERAPY STUDIES. IV. THE PROTECTIVE ACTION OF MERCAPTOALKYLAMINES AGAINST ALKYLATING AGENTS.
    RUTMAN RJ; LEWIS FS; PRICE CC
    Cancer Res; 1964 May; 24():626-33. PubMed ID: 14188465
    [No Abstract]   [Full Text] [Related]  

  • 54. EFFECT OF DRUGS ON CELLS IN VITRO.
    ONESTI P; WOODLIFF HJ
    Br Med J; 1963 Dec; 2(5371):1534. PubMed ID: 14063095
    [No Abstract]   [Full Text] [Related]  

  • 55. AKR mouse leukemic cells in tissue culture. II. Immunologic studies on the AKR 87 cell line.
    Duś D; Harlozińska A; Skriabin A; Richter R
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):727-40. PubMed ID: 187141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. STRUCTURE-ACTION RELATIONSHIPS OF CORTICOSTEROID COMPOUNDS AS INHIBITORS OF LEUKEMIC L5187Y CELL REPRODUCTION IN VIVO AND IN VITRO.
    JAFFE JJ; FISCHER GA; WELCH AD
    Biochem Pharmacol; 1963 Oct; 12():1081-90. PubMed ID: 14074108
    [No Abstract]   [Full Text] [Related]  

  • 57. III. IMPROVEMENT OF CANCER CHEMOTHERAPY IN MAN.
    BURCHENAL JH
    Acta Unio Int Contra Cancrum; 1964; 20():48-51. PubMed ID: 14151968
    [No Abstract]   [Full Text] [Related]  

  • 58. STUDIES OF LEUKEMIA L1210 HOMOGRAFT IN SWISS HA-ICR MICE.
    BRADNER WT; BACHMAN S; PINDELL MH
    Cancer Chemother Rep; 1964 Jul; 39():21-39. PubMed ID: 14201273
    [No Abstract]   [Full Text] [Related]  

  • 59. [EXPERIMENTAL ANTICANCER STUDIES. 23. FURTHER EXPERIMENTS ON THE ANTITUMOR ACTIVITY OF 4-AMINO-6-OCTYLRESORCINOL HYDROCHLORIDE].
    KOSHIURA R; KOSHIMURA S; BANDO Y
    Gan; 1964 Oct; 55():433-41. PubMed ID: 14247592
    [No Abstract]   [Full Text] [Related]  

  • 60. NEOCARZINOSTATIN, AN ANTITUMOR ANTIBIOTIC OF HIGH MOLECULAR WEIGHT. ISOLATION, PHYSIOCHEMICAL PROPERTIES AND BIOLOGICAL ACTIVITIES.
    ISHIDA N; MIYAZAKI K; KUMAGAI K; RIKIMARU M
    J Antibiot (Tokyo); 1965 Mar; 18():68-76. PubMed ID: 14326086
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.